v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Operating activities    
Net income $ 9,343 $ 14,914
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for allowance for credit losses on accounts and notes receivable 1,712 604
Depreciation and amortization 18,343 17,674
Deferred income taxes 1,157 532
Stock-based compensation expense 3,669 (370)
Impairment loss 6,308 7,554
Loss on disposal of property and equipment 151 688
Other (97) 302
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 1,344 5,750
Income tax receivable (541) 660
Inventories (1,881) (1,981)
Prepaid expenses and other current assets (4,854) (2,252)
Other assets and liabilities (2,591) 1,873
Accounts payable 5,242 (14,546)
Income and other taxes payable 3,144 4,718
Accrued expenses and other current liabilities (11,911) (18,166)
Deferred revenue (2,794) (1,284)
Advertising fund assets and liabilities 5,592 (4,683)
Net cash provided by operating activities 31,336 11,987
Investing activities    
Purchases of property and equipment (12,231) (13,058)
Notes issued 0 (154)
Repayments of notes issued 978 886
Proceeds from investments 4,739 2,275
Other (569) (101)
Net cash used in investing activities (7,083) (10,152)
Financing activities    
Net (repayments of) proceeds from revolving credit facilities (196,838) 5,300
Proceeds from term loan 200,000 0
Debt issuance costs (2,991) 0
Proceeds from exercise of stock options 0 840
Dividends paid to common stockholders (15,174) (15,068)
Tax payments for equity award issuances (1,120) (3,192)
Distributions to noncontrolling interests (339) (231)
Principal payments on finance leases (2,392) (2,433)
Other 287 182
Net cash used in financing activities (18,567) (14,602)
Effect of exchange rate changes on cash and cash equivalents 371 (52)
Change in cash and cash equivalents 6,057 (12,819)
Cash and cash equivalents at beginning of period 37,955 40,587
Cash and cash equivalents at end of period $ 44,012 $ 27,768

Source

10-Q PDF XBRL Zip